Thank you to our sponsors
AboutKidsHealth is proud to partner with the following sponsors as they support our mission to improve the health and wellbeing of children in Canada and around the world by making accessible health care information available via the internet.
Our Sponsors
Timing of maintenance phenytoin therapy after intravenous loading dose
J J Riviello Jr et al. Pediatr Neurol. 1991 Jul-Aug.
Abstract
The specific timing of maintenance phenytoin therapy in children has not been addressed. Prevention of a subtherapeutic phenytoin level is important for seizure control. We devised a protocol using an 18 mg/kg loading dose of phenytoin with serial levels (obtained after 2,6,12 hours) and analyzed the results in 20 consecutive patients. A therapeutic level (greater than 10 micrograms/ml) was present in all patients at 2 hours, in 16 of 20 at 6 hours, and in 10 of 20 at 12 hours. The patients were divided into 2 groups by the 12-hour levels: group I: therapeutic level; and group II: subtherapeutic level. The mean 2-hour level in group I was 22.7 micrograms/ml versus 15.6 micrograms/ml in group II (P less than 0.001). The mean decline in plasma concentration in individual patients was 0.7 micrograms/ml/hr in group I versus 1.02 micrograms/ml/hr in group II (P less than 0.05). We now use the 2-hour level to decide the timing of maintenance phenytoin therapy and have devised an equation to estimate the duration of the therapeutic range. Phenytoin can be administered at 12 hours when the 2-hour level is satisfactory or earlier when the 2-hour level indicates that a subtherapeutic level will occur.
Similar articles
Single-dose oral phenytoin loading.
Osborn HH, Zisfein J, Sparano R. Osborn HH, et al. Ann Emerg Med. 1987 Apr;16(4):407-12. doi: 10.1016/s0196-0644(87)80360-8. Ann Emerg Med. 1987. PMID: 3826809 Clinical Trial.
An effective dose schedule for phenytoin treatment of status epilepticus in infancy and childhood.
Albani M. Albani M. Neuropadiatrie. 1977 Aug;8(3):286-92. doi: 10.1055/s-0028-1091524. Neuropadiatrie. 1977. PMID: 578299
Kinetics of intravenous phenytoin in children.
Koren G, Brand N, Halkin H, Dany S, Shahar E, Barzilay Z. Koren G, et al. Pediatr Pharmacol (New York). 1984;4(1):31-8. Pediatr Pharmacol (New York). 1984. PMID: 6739185
Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.
Meek PD, Davis SN, Collins DM, Gidal BE, Rutecki PA, Burstein AH, Fischer JH, Leppik IE, Ramsay RE. Meek PD, et al. Arch Intern Med. 1999 Dec 13-27;159(22):2639-44. doi: 10.1001/archinte.159.22.2639. Arch Intern Med. 1999. PMID: 10597754 Review.
Management of acute seizure and status epilepticus in pediatric emergency.
Sasidaran K, Singhi S, Singhi P. Sasidaran K, et al. Indian J Pediatr. 2012 Apr;79(4):510-7. doi: 10.1007/s12098-011-0604-9. Epub 2011 Nov 26. Indian J Pediatr. 2012. PMID: 22120613 Review.
Cited by
Antiepileptic Drug Therapy for Status Epilepticus.
Kim D, Kim JM, Cho YW, Yang KI, Kim DW, Lee ST, No YJ, Seo JG, Byun JI, Kang KW, Kim KT; Drug Committee of Korean Epilepsy Society. Kim D, et al. J Clin Neurol. 2021 Jan;17(1):11-19. doi: 10.3988/jcn.2021.17.1.11. J Clin Neurol. 2021. PMID: 33480193 Free PMC article. Review.
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
Battino D, Estienne M, Avanzini G. Battino D, et al. Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004. Clin Pharmacokinet. 1995. PMID: 8582119 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information